이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Pharma Mar 대차 대조표 상태
재무 상태 기준 확인 4/6
Pharma Mar 의 총 주주 지분은 €192.7M 이고 총 부채는 €36.8M, 이는 부채 대 자기자본 비율을 19.1% 로 가져옵니다. 총자산과 총부채는 각각 €333.9M 및 €141.2M 입니다.
주요 정보
19.1%
부채 비율
€36.81m
부채
| 이자 보상 비율 | n/a |
| 현금 | €159.72m |
| 주식 | €192.67m |
| 총 부채 | €141.22m |
| 총 자산 | €333.90m |
최근 재무 상태 업데이트
Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden
Jan 25
Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
Feb 09We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease
Oct 27Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?
Jul 15Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet
Apr 11Is Pharma Mar (BME:PHM) Using Too Much Debt?
Jan 09Recent updates
Pharma Mar (BME:PHM) Will Pay A Larger Dividend Than Last Year At €0.65
Jun 01Pharma Mar, S.A.'s (BME:PHM) Shares Bounce 29% But Its Business Still Trails The Industry
May 28Pharma Mar, S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 03Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden
Jan 25Pharma Mar, S.A. (BME:PHM) Shares Could Be 30% Below Their Intrinsic Value Estimate
Apr 28We Believe That Pharma Mar's (BME:PHM) Weak Earnings Are A Good Indicator Of Underlying Profitability
Mar 08Analyst Forecasts Just Became More Bearish On Pharma Mar, S.A. (BME:PHM)
Mar 05Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
Feb 09We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease
Oct 27An Intrinsic Calculation For Pharma Mar, S.A. (BME:PHM) Suggests It's 21% Undervalued
Sep 27Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?
Jul 15Growth Investors: Industry Analysts Just Upgraded Their Pharma Mar, S.A. (BME:PHM) Revenue Forecasts By 24%
May 04Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet
Apr 11There Is A Reason Pharma Mar, S.A.'s (BME:PHM) Price Is Undemanding
Mar 16Is Pharma Mar (BME:PHM) Using Too Much Debt?
Jan 09Pharma Mar (BME:PHM) Seems To Use Debt Quite Sensibly
Sep 08News Flash: Analysts Just Made A Meaningful Upgrade To Their Pharma Mar, S.A. (BME:PHM) Forecasts
Aug 03Here's Why I Think Pharma Mar (BME:PHM) Is An Interesting Stock
May 31Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
May 10Is Pharma Mar, S.A. (BME:PHM) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 08Announcing: Pharma Mar (BME:PHM) Stock Increased An Energizing 231% In The Last Five Years
Jan 14Is Pharma Mar (BME:PHM) A Risky Investment?
Nov 19재무 상태 분석
단기부채: PHM 의 단기 자산 ( €241.4M )이 단기 부채( €92.3M ).
장기 부채: PHM 의 단기 자산( €241.4M )이 장기 부채( €49.0M ).
부채 대 자본 내역 및 분석
부채 수준: PHM 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: PHM 의 부채 대 자기자본 비율은 지난 5년간 1262.2% 에서 19.1% 로 감소했습니다.
부채 범위: PHM 의 영업현금흐름이 마이너스이므로 부채가 제대로 상환되지 않습니다.
이자 보장: PHM 의 부채에 대한 이자 지급이 EBIT에 의해 잘 충당되었는지 판단할 데이터가 부족합니다.